Systems pharmacology dissection of the anti-inflammatory mechanism for the medicinal herb Folium Eriobotryae

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 2913-2941

  Zhang, Jingxiao ^a   Li, Yan ^a   Chen, Su Shing ^b,c   Zhang, Lilei ^d   Wang, Jinghui ^a   Yang, Yinfeng ^a   Zhang, Shuwei ^a   Pan, Yanqiu ^a   Wang, Yonghua ^e   Yang, Ling ^f  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b UNIVERSITY OF FLORIDA   (United States)

^c J Crayton Pruitt Family Department of Biomedical Engineering   (United States)

^d HUBEI UNIVERSITY FOR NATIONALITIES   (China)

^e NORTHWEST A F UNIVERSITY   (China)

^f DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Anti inflammation; Folium Eriobotryae; Herbal medicine; Systems pharmacology

Indexed keywords

3 EPIURSOLIC ACID; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ARJUNOLIC ACID; CAFFEIC ACID; CHLOROGENIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DELTA 7 STIGMASTENOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; KAEMPFEROL; LINGUERSINOL; MASLINIC ACID; METHYL ARJUNOLATE; METHYL BETULINATE; METHYL MASLINATE; METHYL URSOLATE; MITOGEN ACTIVATED PROTEIN KINASE; OLEANOLIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POMOLIC ACID; PROSTAGLANDIN SYNTHASE; QUERCETIN; RUTOSIDE; SITOSTEROL; TORMENTIC ACID; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; BIOAVAILABILITY; BIOLOGICAL MODEL; COMPOUND TARGET NETWORK; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; DRUG TARGETING; EPITHELIUM CELL; FOLIUM ERIOBOTRYAE; INFORMATION PROCESSING; MEDICINAL PLANT; MOLECULAR DOCKING; NETWORK LEARNING; NEUROPROTECTION; NONHUMAN; RHEUMATOID ARTHRITIS; SANGUISORBA; SIGNAL TRANSDUCTION; TARGET DISEASE NETWORK; TARGET PATHWAY NETWORK; THEORY-PRACTICE RELATIONSHIP; WESTERN MEDICINE; CACO 2 CELL LINE; CELL LINE; CHEMISTRY; DRUG EFFECTS; ERIOBOTRYA; FACTUAL DATABASE; HUMAN; METABOLISM; PERMEABILITY;

ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CELL LINE; DATABASES, FACTUAL; ERIOBOTRYA; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PERMEABILITY; PLANTS, MEDICINAL; SIGNAL TRANSDUCTION;

EID: 84922009063     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16022913     Document Type: Article

References (102)

1. Tracey, K.J. The inflammatory reflex. Nature 2002, 420, 853-859.
2. Crofford, L.J. Use of NSAIDs in treating patients with arthritis. Arthritis Res. Ther. 2013, 15, doi:10.1186/ar4174.
3. Li, R.W.; Myers, S.P.; Leach, D.N.; Lin, G.D.; Leach, G. A cross-cultural study: Anti-inflammatory activity of Australian and Chinese plants. J. Ethnopharmacol. 2003, 85, 25-32.
4. Martinez Gonzalez, J.; Badimon, L. Mechanisms underlying the cardiovascular effects of COX-inhibition: Benefits and risks. Curr. Pharm. Des. 2007, 13, 2215-2227.
5. Gilroy, D.W.; Lawrence, T.; Perretti, M.; Rossi, A.G. Inflammatory resolution: New opportunities for drug discovery. Nat. Rev. Drug Discov. 2004, 3, 401-416.
6. Wong, D.; Wang, M.; Cheng, Y.; FitzGerald, G.A. Cardiovascular hazard and non-steroidal anti-inflammatory drugs. Curr. Opin. Pharmacol. 2005, 5, 204-210.
7. Ernst, M. Harmless herbs? A review of the recent literature. Am. J. Med. 1998, 104, 170-178.
8. Shen, Y.C.; Chen, C.F.; Chiou, W.F. Andrographolide prevents oxygen radical production by human neutrophils: Possible mechanism(s) involved in its anti-inflammatory effect. Br. J. Pharmacol. 2002, 135, 399-406.
9. Mishra, S.K.; Sangwan, N.S.; Sangwan, R.S. Andrographis paniculata (Kalmegh): A review. Pharmacog. Rev. 2007, 1, 283-298.
10. Lee, K.C.; Chang, H.H.; Chung, Y.H.; Lee, T.Y. Andrographolide acts as an anti-inflammatory agent in LPS-stimulated RAW264.7 macrophages by inhibiting STAT3-mediated suppression of the NF-κB pathway. J. Ethnopharmacol. 2011, 135, 678-684.
11. Tang, D.; Li, H.J.; Chen, J.; Guo, C.W.; Li, P. Rapid and simple method for screening of natural antioxidants from Chinese herb Flos Lonicerae japonicae by DPPH-HPLC-DAD-TOF/MS. J. Sep. Sci. 2008, 31, 3519-3526.
12. Shang, X.; Pan, H.; Li, M.; Miao, X.; Ding, H. Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J. Ethnopharmacol. 2011, 138, 1-21.
13. Kang, O.H.; Choi, J.G.; Lee, J.H.; Kwon, D.Y. Luteolin isolated from the flowers of Lonicera japonica suppresses inflammatory mediator release by blocking NF-κB and MAPKs activation pathways in HMC-1 cells. Molecules 2010, 15, 385-398.
14. Qiusheng, Z.; Xiling, S.; Gang, L.; Meng, S.; Changhai, W. Protective effects of luteolin-7-glucoside against liver injury caused by carbon tetrachloride in rats. Pharmazie 2004, 59, 286-288.
15. Ito, H.; Kobayashi, E.; Li, S.H.; Hatano, T.; Sugita, D.; Kubo, N.; Shimura, S.; Itoh, Y.; Yoshida, T. Megastigmane glycosides and an acylated triterpenoid from Eriobotrya japonica. J. Nat. Prod. 2001, 64, 737-740.
16. Yuan, X.; Fu, W.; Zheng, Q.S.; Ju, B.; Xu, B. Antioxidative and cardioprotective activities of total flavonoids from Moldavian balm (Dracocephalum moldavica L.). In Proceedings of the 2010 International Conference on Bioinformatics and Biomedical Technology (ICBBT), Chengdu, China, 16-18 April 2010.
17. Li, Y.L.; Yang, X.W.; Li, S.M.; Shen, Y.H.; Zeng, H.W.; Liu, X.H.; Tang, J.; Zhang, W.D. Terpenoid constituents of Abies chensiensis with potential anti-inflammatory activity. J. Nat. Prod. 2009, 72, 1065-1068.
18. Lee, C.H.; Wu, S.L.; Chen, J.C.; Li, C.C.; Lo, H.Y.; Cheng, W.Y.; Lin, J.G.; Chang, Y.H.; Hsiang, C.Y.; Ho, T.Y. Eriobotrya japonica leaf and its triterpenes inhibited lipopolysaccharide-induced cytokines and inducible enzyme production via the nuclear factor-kappaB signaling pathway in lung epithelial cells. Am. J. Chin. Med. 2008, 36, 1185-1198.
19. Hämäläinen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E. Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediat. Inflamm. 2007, 2007, 45673.
20. Yang, M.; Cheng, C.; Yang, J.; Guo, D.A. Metabolite profiling and characterization for medicinal herbal remedies. Curr. Drug Metable 2012, 13, 535-557.
21. Lu, A.P.; Bian, Z.X.; Chen, K.J. Bridging the traditional Chinese medicine pattern classification and biomedical disease diagnosis with systems biology. Chin. J. Integr. Med. 2012, 18, 883-890.
22. Berger, S.I.; Iyengar, R. Network analyses in systems pharmacology. Bioinformatics 2009, 25, 2466-2472.
23. Cheng, F.; Liu, C.; Jiang, J.; Lu, W.; Li, W.; Liu, G.; Zhou, W.; Huang, J.; Tang, Y. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. 2012, 8, e1002503.
24. Li, S.; Zhang, B.; Zhang, N. Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst. Biol. 2011, 5, doi:10.1186/1752-0509- 5-S1-S10.
25. Chan, L.; Lowes, S.; Hirst, B.H. The ABCs of drug transport in intestine and liver: Efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 2004, 21, 25-51.
26. Walters, W.P.; Murcko, M.A. Prediction of 'drug-likeness'. Adv. Drug Deliv. Rev. 2002, 54, 255-271.
27. Liu, J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 1995, 49, 57-68.
28. Wen, X.; Sun, H.; Liu, J.; Cheng, K.; Zhang, P.; Zhang, L.; Hao, J.; Zhang, L.; Ni, P.; Zographos, S.E. Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: Synthesis, structure-activity relationships, and X-ray crystallographic studies. J. Med. Chem. 2008, 51, 3540-3554.
29. Price, K.; Johnson, I.; Fenwick, G.; Malinow, M. The chemistry and biological significance of saponins in foods and feedingstuffs. Crit. Rev. Food Sci. Nutr. 1987, 26, 27-135.
30. Singh, G.B.; Singh, S.; Bani, S.; Gupta, B.D.; Banerjee, S.K. Anti-inflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol. 1992, 44, 456-458.
31. Shimizu, M.; Fukumura, H.; Tsuji, H.; Tanaami, S.; Hayashi, T.; Morita, N. Anti-inflammatory constituents of topically applied crude drugs. I. Constituents and anti-inflammatory effect of Eriobotrya japonica Lindl. Chem. Pharm. Bull. 1986, 34, 2614-2617.
32. Ma, C.M.; Cai, S.Q.; Cui, J.R.; Wang, R.Q.; Tu, P.F.; Hattori, M.; Daneshtalab, M. The cytotoxic activity of ursolic acid derivatives. Eur. J. Med. Chem. 2005, 40, 582-589.
33. Muegge, I. Selection criteria for drug-like compounds. Med. Res. Rev. 2003, 23, 302-321.
34. dos Santos, M.D.; Almeida, M.C.; Lopes, N.P.; de Souza, G.E. Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol. Pharm. Bull. 2006, 29, 2236-2240.
35. Schinella, G.; Aquila, S.; Dade, M.; Giner, R.; Recio Mdel, C.; Spegazzini, E.; de Buschiazzo, P.; Tournier, H.; Rios, J.L. Anti-inflammatory and apoptotic activities of pomolic acid isolated from Cecropia pachystachya. Planta Med. 2008, 74, 215-220.
36. Navarro, A.; de Las Heras, B.; Villar, A. Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideritis foetens CLEM. Biol. Pharm. Bull. 2001, 24, 470-473.
37. Moreno, J.J. Effect of olive oil minor components on oxidative stress and arachidonic acid mobilization and metabolism by macrophages RAW 264.7. Free Radic. Biol. Med. 2003, 35, 1073-1081.
38. Banno, N.; Akihisa, T.; Tokuda, H.; Yasukawa, K.; Taguchi, Y.; Akazawa, H.; Ukiya, M.; Kimura, Y.; Suzuki, T.; Nishino, H. Anti-inflammatory and antitumor-promoting effects of the triterpene acids from the leaves of Eriobotrya japonica. Biol. Pharm. Bull. 2005, 28, 1995-1999.
39. Metodiewa, D.; Kochman, A.; Karolczak, S. Evidence for antiradical and antioxidant properties of four biologically active N,N-Diethylaminoethyl ethers of flavaone oximes: A comparison with natural polyphenolic flavonoid rutin action. IUBMB Life 1997, 41, 1067-1075.
40. Yang, L.; Sun, Z.; Zu, Y.; Zhao, C.; Sun, X.; Zhang, Z.; Zhang, L. Physicochemical properties and oral bioavailability of ursolic acid nanoparticles using supercritical anti-solvent (SAS) process. Food Chem. 2012, 132, 319-325.
41. Ju, J.H.; Zhou, L.; Zheng, R.X.; Wang, C.L.; Yang, J.S. Determination of ursolic acid in Eriobotrya japonica by HPLC analysis. China Pharm. J. 2003, 38, 657-658.
42. Gonthier, M.P.; Verny, M.A.; Besson, C.; Remesy, C.; Scalbert, A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J. Nutr. 2003, 133, 1853-1859.
43. Shan, J.; Fu, J.; Zhao, Z.; Kong, X.; Huang, H.; Luo, L.; Yin, Z. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264. 7 cells through suppressing NF-κB and JNK/AP-1 activation. Int. Immunopharmacol. 2009, 9, 1042-1048.
44. Konishi, Y.; Kobayashi, S. Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal caco-2 cell monolayers. J. Agric. Food Chem. 2004, 52, 2518-2526.
45. Gulcin, I. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 2006, 217, 213-220.
46. Chao, P.C.; Hsu, C.C.; Yin, M.C. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr. Metable 2009, 6, doi:10.1186/ 1743-7075-6-33.
47. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073S-2085S.
48. Li, P.; Qi, L.W.; Liu, E.H.; Zhou, J.L.; Wen, X.D. Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models. Trac-Trend Anal. Chem. 2008, 27, 66-77.
49. Zhang, J.; Li, Y.; Chen, X.; Pan, Y.; Zhang, S.; Wang, Y. Systems pharmacology dissection of multi-scale mechanisms of action for herbal medicines in stroke treatment and prevention. PLoS One 2014, 9, e102506.
50. Huang, C.; Zheng, C.; Li, Y.; Wang, Y.; Lu, A.; Yang, L. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief. Bioinf. 2013, 15, 710-733.
51. Vane, J.; Botting, R. New insights into the mode of action of anti-inflammatory drugs. Inflamm. Res. 1995, 44, 1-10.
52. Gerstenfeld, L.C.; Thiede, M.; Seibert, K.; Mielke, C.; Phippard, D.; Svagr, B.; Cullinane, D.; Einhorn, T.A. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J. Orthop. Res. 2003, 21, 670-675.
53. Espinoza-Fonseca, L.M. The benefits of the multi-target approach in drug design and discovery. Bioorg. Med. Chem. 2006, 14, 896-897.
54. Albert, R.; Jeong, H.; Barabási, A.L. Error and attack tolerance of complex networks. Nature 2000, 406, 378-382.
55. Yıldırım, M.A.; Goh, K.I.; Cusick, M.E.; Barabási, A.L.; Vidal, M. Drug-target network. Nat. Biotechnol. 2007, 25, 1119-1126.
56. Geraets, L.; Moonen, H.J.; Brauers, K.; Wouters, E.F.; Bast, A.; Hageman, G.J. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J. Nutr. 2007, 137, 2190-2195.
57. Fang, X.K.; Gao, J.; Zhu, D.N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci. 2008, 82, 615-622.
58. Berger, J.P.; Akiyama, T.E.; Meinke, P.T. PPARs: Therapeutic targets for metabolic disease. Trends Pharmacol. Sci. 2005, 26, 244-251.
59. Esposito, E.; Cuzzocrea, S. TNF-α as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr. Med. Chem. 2009, 16, 3152-3167.
60. Kumar, S.; Boehm, J.; Lee, J.C. p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov. 2003, 2, 717-726.
61. Ito, H.; Kobayashi, E.; Takamatsu, Y.; Li, S.H.; Hatano, T.; Sakagami, H.; Kusama, K.; Satoh, K.; Sugita, D.; Shimura, S.; Itoh Y.; Yoshida T. Polyphenols from Eriobotrya japonica and their cytotoxicity against human oral tumor cell lines. Chem. Pharm. Bull. 2000, 48, 687-693.
62. Haegeman, G. Inhibition of signal transduction pathways involved in inflammation. Eur. Respir. J. Suppl. 2003, 44, 16s-19s.
63. Tak, P.P.; Firestein, G.S. NF-κB: A key role in inflammatory diseases. J. Clin. Investig. 2001, 107, 7-11.
64. Balough, K.; McCubbin, M.; Weinberger, M.; Smits, W.; Ahrens, R.; Fick, R. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 1995, 20, 63-70.
65. Erdman, S.E.; Poutahidis, T. Cancer inflammation and regulatory T cells. Int. J. Cancer 2010, 127, 768-779.
66. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
67. Cha, D.S.; Shin, T.Y.; Eun, J.S.; Kim, D.K.; Jeon, H. Anti-metastatic properties of the leaves of Eriobotrya japonica. Arch. Pharm. Res. 2011, 34, 425-436.
68. Kim, M.; You, M.; Rhuy, D.; Kim, Y.; Baek, H.; Kim, H. Loquat (Eriobotrya japonica) extracts suppress the adhesion, migration and invasion of human breast cancer cell line. Nutr. Res. Pract. 2009, 3, 259-264.
69. Uto, T.; Sakamoto, A.; Tung, N.H.; Fujiki, T.; Kishihara, K.; Oiso, S.; Kariyazono, H.; Morinaga, O.; Shoyama, Y. Anti-proliferative activities and apoptosis induction by triterpenes derived from Eriobotrya japonica in human leukemia cell lines. Int. J. Mol. Sci. 2013, 14, 4106-4120.
70. Lu, H.; Chen, J.; Li, W.L.; Ren, B.R.; Wu, J.L.; Kang, H.Y.; Zhang, H.Q.; Adams, A.; de Kimpe, N. Hypoglycemic and hypolipidemic effects of the total triterpene acid fraction from Folium Eriobotryae. J. Ethnopharmacol. 2009, 122, 486-491.
71. Li, W.L.; Wu, J.L.; Ren, B.R.; Chen, J.; Lu, C.G. Pharmacological studies on anti-hyperglycemic effect of Folium Eriobotryae. Am. J. Chin. Med. 2007, 35, 705-711.
72. Chen, J.; Li, W.L.; Wu, J.L.; Ren, B.R.; Zhang, H.Q. Hypoglycemic effects of a sesquiterpene glycoside isolated from leaves of loquat (Eriobotrya japonica (Thunb.) Lindl.). Phytomedicine 2008, 15, 98-102.
73. Ge, J.F.; Wang, T.Y.; Zhao, B.; Lv, X.W.; Jin, Y.; Peng, L.; Yu, S.C.; Li, J. Anti-inflammatory effect of triterpenoic acids of Eriobotrya japonica (Thunb.) Lindl. leaf on rat model of chronic bronchitis. Am. J. Chin. Med. 2009, 37, 309-321.
74. Huang, Y.; Li, J.; Cao, Q.; Yu, S.C.; Lv, X.W.; Jin, Y.; Zhang, L.; Zou, Y.H.; Ge, J.F. Anti-oxidative effect of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. leaf in chronic bronchitis rats. Life Sci. 2006, 78, 2749-2757.
75. Uto, T.; Suangkaew, N.; Morinaga, O.; Kariyazono, H.; Oiso, S.; Shoyama, Y. Eriobotryae folium extract suppresses LPS-induced iNOS and COX-2 expression by inhibition of NF-kappaB and MAPK activation in murine macrophages. Am. J. Chin. Med. 2010, 38, 985-94.
76. Kim, S.H.; Shin, T.Y. Anti-inflammatory effect of leaves of Eriobotrya japonica correlating with attenuation of p38 MAPK, ERK, and NF-kappaB activation in mast cells. Toxicol. In Vitro 2009, 23, 1215-1219.
77. Choi, Y.G.; Seok, Y.H.; Yeo, S.; Jeong, M.Y.; Lim, S. Protective changes of inflammation-related gene expression by the leaves of Eriobotrya japonica in the LPS-stimulated human gingival fibroblast: microarray analysis. J. Ethnopharmacol. 2011, 135, 636-645.
78. Cha, D.S.; Eun, J.S.; Jeon, H. Anti-inflammatory and antinociceptive properties of the leaves of Eriobotrya japonica. J. Ethnopharmacol. 2011, 134, 305-312.
79. Ito, H.; Kobayashi, E.; Li, S.H.; Hatano, T.; Sugita, D.; Kubo, N.; Shimura, S.; Itoh, Y.; Tokuda, H.; Nishino, H.; Yoshida, T. Antitumor activity of compounds isolated from leaves of Eriobotrya japonica. J. Agric. Food Chem. 2002, 50, 2400-2403.
80. Kim, S.H.; Kwon, Y.E.; Park, W.H.; Jeon, H.; Shin, T.Y. Effect of leaves of Eriobotrya japonica on anaphylactic allergic reaction and production of tumor necrosis factor-alpha. Immunopharmacol. Immunotoxicol. 2009, 31, 314-319.
81. Chen, J.; Li, W.L.; Wu, J.L.; Ren, B.R.; Zhang, H.Q. Euscaphic acid, a new hypoglycemic natural product from Folium Eriobotryae. Pharmazie 2008, 63, 765-767.
82. Qa'dan, F.; Verspohl, E.J.; Nahrstedt, A.; Petereit, F.; Matalka, K.Z. Cinchonain Ib isolated from Eriobotrya japonica induces insulin secretion in vitro and in vivo. J. Ethnopharmacol. 2009, 124, 224-227.
83. De Tommasi, N.; De Simone, F.; Cirino, G.; Cicala, C.; Pizza, C. Hypoglycemic effects of sesquiterpene glycosides and polyhydroxylated triterpenoids of Eriobotrya japonica. Planta Med. 1991, 57, 414-416.
84. Tanaka, K.; Nishizono, S.; Makino, N.; Tamaru, S.; Terai, O.; Ikeda, I. Hypoglycemic activity of Eriobotrya japonica seeds in type 2 diabetic rats and mice. Biosci. Biotechnol. Biochem. 2008, 72, 686-693.
85. Noreen, W.; Wadood, A.; Hidayat, H.K.; Wahid, S.A. Effect of Eriobotrya japonica on blood glucose levels of normal and alloxan-diabetic rabbits. Planta Med. 1988, 54, 196-199.
86. Gumy, C.; Thurnbichler, C.; Aubry, E.M.; Balazs, Z.; Pfisterer, P.; Baumgartner, L.; Stuppner, H.; Odermatt, A.; Rollinger, J.M. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines. Fitoterapia 2009, 80, 200-205.
87. Lu, H.; Chen, J.; Li, W.L.; Ren, B.R.; Wu, J.L.; Zhang, H.Q. Hypoglycemic effect of the total flavonoid fraction from folium Eriobotryae. Phytomedicine 2009, 16, 967-971.
88. De Tommasi, N.; De Simone, F.; Pizza, C.; Mahmood, N.; Moore, P.S.; Conti, C.; Orsi, N.; Stein, M.L. Constituents of Eriobotrya japonica. A study of their antiviral properties. J. Nat. Prod. 1992, 55, 1067-1073.
89. Kim, M.J.; Lee, J.; Seong, A.R.; Lee, Y.H.; Kim, Y.J.; Baek, H.Y.; Jun, W.J.; Yoon, H.G. Neuroprotective effects of Eriobotrya japonica against beta-amyloid-induced oxidative stress and memory impairment. Food Chem. Toxicol. 2011, 49, 780-784.
90. Li, X.; Xu, X.; Wang, J.; Yu, H.; Wang, X.; Yang, H.; Xu, H.; Tang, S.; Li, Y.; Yang, L. A System-level investigation into the mechanisms of Chinese traditional medicine: Compound danshen formula for cardiovascular disease treatment. PLoS One 2012, 7, e43918.
91. Van de Waterbeemd, H.; Gifford, E. ADMET in silico modelling: Towards prediction paradise? Nat. Rev. Drug Discov. 2003, 2, 192-204.
92. Liu, H.; Wang, J.; Zhou, W.; Wang, Y.; Yang, L. Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice. J. Ethnopharmacol. 2013, 146, 773-793.
93. Xu, X.; Zhang, W.; Huang, C.; Li, Y.; Yu, H.; Wang, Y.; Duan, J.; Ling, Y. A novel chemometric method for the prediction of human oral bioavailability. Int. J. Mol. Sci. 2012, 13, 6964-6982.
94. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
95. Ano, R.; Kimura, Y.; Shima, M.; Matsuno, R.; Ueno, T.; Akamatsu, M. Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: Application to prediction of Caco-2 cell permeability. Bioorg. Med. Chem. 2004, 12, 257-264.
96. Hu, G.X.; Zhang, C.H.; Zhao, W.N.; Yu, Q.S. QSPR study on the permeability of drugs across Caco-2 monolayer. J. Zhejiang Univ. 2009, 3, 304-308.
97. Zhu, F.; Shi, Z.; Qin, C.; Tao, L.; Liu, X.; Xu, F.; Zhang, L.; Song, Y.; Liu, X.; Zhang, J. Therapeutic target database update 2012: A resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012, 40, D1128-D1136.
98. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V. DrugBank 3.0: A comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011, 39, D1035-D1041.
99. Yu, H.; Chen, J.; Xu, X.; Li, Y.; Zhao, H.; Fang, Y.; Li, X.; Zhou, W.; Wang, W.; Wang, Y. A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. PLoS One 2012, 7, e37608.
100. Whirl-Carrillo, M.; McDonagh, E.; Hebert, J.; Gong, L.; Sangkuhl, K.; Thorn, C.; Altman, R.; Klein, T. Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 2012, 92, 414-417.
101. Schwede, T.; Kopp, J.; Guex, N.; Peitsch, M.C. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 2003, 31, 3381-3385.
102. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N.S.; Wang, J.T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.